Stock hits 52-week low as company reports disappointing financials

  • Agilon Health shares drop 17% after wider-than-expected 3Q loss
  • Stock hits 52-week low of $12.14
  • Quarterly loss of $31.4 million, compared to $30.7 million last year
  • Revenue for the quarter at $1.22 billion, compared to $694.9 million last year
  • Total members on Agilon platform rise to 508,000
  • Company expects lower revenue in fiscal 2023

Agilon Health shares plunged 17% to $14.07 following the release of their third-quarter financial results. The company reported a wider-than-expected loss of $31.4 million, compared to $30.7 million in the same quarter last year. Additionally, revenue for the quarter came in at $1.22 billion, significantly higher than last year’s $694.9 million. However, this fell short of analysts’ expectations of $1.13 billion. The number of total members on the Agilon platform increased to 508,000 as of September 30. Looking ahead, the company anticipates lower revenue in fiscal 2023, projecting $4.31 billion to $4.32 billion, compared to analysts’ estimate of $4.53 billion.

Public Companies: Agilon Health (N/A)
Private Companies:
Key People:

Factuality Level: 8
Justification: The article provides specific financial information about Agilon Health’s third-quarter loss, stock performance, and revenue. It also includes comparisons to previous quarters and analyst expectations. The information appears to be factual and based on verifiable data.

Noise Level: 3
Justification: The article provides relevant information about Agilon Health’s financial performance, including its third-quarter loss, stock price, and revenue. It also includes comparisons to analysts’ expectations. However, it lacks in-depth analysis, antifragility considerations, and accountability of powerful people. The article stays on topic and supports its claims with data and examples. Overall, the noise level is relatively low.

Financial Relevance: Yes
Financial Markets Impacted: Agilon Health shares

Presence of Extreme Event: No
Nature of Extreme Event: No
Impact Rating of the Extreme Event: No
Justification: The article pertains to financial topics as it discusses the financial performance of Agilon Health and its impact on the company’s shares. However, there is no mention of any extreme event or its impact.

Reported publicly: www.marketwatch.com